IMMUNE PHARMACEUTICALS INC - COM (IMNP)

CUSIP: 45254C101

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
175,008
Share change
+7,240
Total reported value
$313,000
Price per share
$1.78
Number of holders
9
Value change
+$8,689
Number of buys
7
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 45254C101?
CUSIP 45254C101 identifies IMNP - IMMUNE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IMMUNE PHARMACEUTICALS INC - COM (IMNP) as of Q1 2015

As of 31 Mar 2015, IMMUNE PHARMACEUTICALS INC - COM (IMNP) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 175,008 shares. The largest 9 holders included KCG Holdings, Inc., Geduld E E, GOLDMAN SACHS GROUP INC, Ifrah Financial Services, Inc., Pictet & Cie (Europe) SA, A.R.T. Advisors, LLC, BlackRock Institutional Trust Company, N.A., LADENBURG THALMANN FINANCIAL SERVICES INC, and UBS Group AG. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.